On Tuesday, Johnson & Johnson (NYSE: JNJ) opened lower -0.74% from the last session, before settling in for the closing price of $207.32. Price fluctuations for JNJ have ranged from $140.68 to $215.18 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 0.55%. Company’s average yearly earnings per share was noted 8.90% at the time writing. With a float of $2.41 billion, this company’s outstanding shares have now reached $2.41 billion.
The extent of productivity of a business whose workforce counts for 139800 workers is very important to gauge.
Johnson & Johnson (JNJ) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Drug Manufacturers – General industry is another important factor to consider. The insider ownership of Johnson & Johnson is 0.12%, while institutional ownership is 74.47%. The most recent insider transaction that took place on Nov 26 ’25, was worth 257,688. In this transaction Director of this company bought 1,250 shares at a rate of $206.15, taking the stock ownership to the 1,849 shares. Before that another transaction happened on Nov 26 ’25, when Company’s 10% Owner sold 6,337 for $10.03, making the entire transaction worth $63,560. This insider now owns 4,040,861 shares in total.
Johnson & Johnson (JNJ) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted 2.04 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 2.01) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.75 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 8.90% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.55% during the next five years compared to 0.55% growth over the previous five years of trading.
Johnson & Johnson (NYSE: JNJ) Trading Performance Indicators
Check out the current performance indicators for Johnson & Johnson (JNJ). In the past quarter, the stock posted a quick ratio of 0.80. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.38. Likewise, its price to free cash flow for the trailing twelve months is 25.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 10.36, a number that is poised to hit 2.53 in the next quarter and is forecasted to reach 11.54 in one year’s time.
Technical Analysis of Johnson & Johnson (JNJ)
The latest stats from [Johnson & Johnson, JNJ] show that its last 5-days average volume of 11.2 million was superior to 8.95 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 36.96%.
During the past 100 days, Johnson & Johnson’s (JNJ) raw stochastic average was set at 80.63%, which indicates a significant increase from 38.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.89 in the past 14 days, which was higher than the 2.82 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $198.38, while its 200-day Moving Average is $172.82. Now, the first resistance to watch is $207.11. This is followed by the second major resistance level at $208.45. The third major resistance level sits at $210.36. If the price goes on to break the first support level at $203.86, it is likely to go to the next support level at $201.95. The third support level lies at $200.61 if the price breaches the second support level.
Johnson & Johnson (NYSE: JNJ) Key Stats
There are currently 2,409,295K shares outstanding in the company with a market cap of 495.78 billion. Presently, the company’s annual sales total 88,821 M according to its annual income of 14,066 M. Last quarter, the company’s sales amounted to 23,993 M and its income totaled 5,152 M.
